A drug that recruits immune cells to fight an aggressive form of lymphoma appears to be more effective than chemotherapy, according to new research from Weill Cornell Medicine.
To better understand, prevent and treat diseases passed from insects to people, the Cornell-led Northeast Regional Center for Excellence in Vector Borne Diseases will launch later this month.
Weill Cornell Medicine announced May 26 that it has been awarded a Gates Foundation Grand Challenges Explorations Grant to enable scientists to develop maps of 54 cities.
Cornell and Weill Cornell Medicine researchers report on the use of biomaterials-based organoids in an attempt to reproduce immune-system events and gain a better understanding of B cells.
Years before COVID-19 turned into a global pandemic, biomolecular engineer Susan Daniel was already looking for ways to defeat it. Now she’s expanding her coronavirus studies, blending engineering with virology and data science.
A Cornell research group reports that a mechanical factor - stiffening of a cancer cell and its matrix - and not a chemical cause could contribute to metastasis in some forms of cancer.
The incidence of metastatic prostate cancer in older men is rising after reaching an all-time low in 2011. The findings suggest a correlation between the increase and a change in prostate cancer screening guidelines recommending against routine PSA testing.
Cornell researchers have identified a type of immune system cell that prevents a patient’s body from attacking donor cells after a bone marrow transplant.
New research by Weill Cornell Medicine investigators could offer researchers a new scientific avenue to pursue treatments for X-linked chromosomal diseases in females such as Rett syndrome.
Genetically mutated cancer cells grow may help explain why patients with a common form of leukemia develop treatment resistance, according to new Weill Cornell Medicine research.